WHA 0.00% 48.7¢ wattle health australia limited

Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-52

  1. 26,847 Posts.
    lightbulb Created with Sketch. 1841
    Never listen to anonymous opinions

    Read the options, but should be verified by own then make own decisions.

    Passed technical review, how long will we need to wait for the results?

    Last year's applications, did get approval fairly fast, around 3 - 5 months, now approval process takes a bit longer, especially CFDA merged with SMRA, did Goldman Sachs said, BAL will get SMRA/CFDA approval, just about when.
    Taking the risk.
 
watchlist Created with Sketch. Add WHA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.